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Intravenous aminophylline is used as a first line treatment for bronchial asthma.
This preparation consists of theophylline or a salt of theophylline dissolved in
a solution of ethylenediamine, which confers greater solubility and reduces the
alkalinity of the drug.1 In clinical usage side effects of tachycardia, seizures and
nausea are well known. We report on the much less common, but clinically
important problemofallergytotheethylenediamine componentofaminophylline.
CASE REPORT. A 57-year-old lady was admitted with an infective exacerb-
ation of chronic bronchitis and emphysema. Initial treatment was with nebulized
bronchodilators, and intravenous aminophylline, hydrocortisone and ampicillin.
Later on the day of admission the patient developed an erythematous macular
rash, initially on the trunk and limbs, but becoming confluent with periorbital
oedema. The rash was hot, itchy and uncomfortable, and the patient had
paraethesia in her limbs. There was no clinical evidence of anaphylaxis and
exfoliation did not occur. No history of drug allergy was given and medical notes
were unavailable at this time. It was suspected the allergen was ampicillin, but
discontinuation ofthis drug provided no relief. The patient remained on nebulized
bronchodilatorsandanintravenous infusionofhydrocortisoneandaminophylline.
When the medical notes became available, close scrutiny revealed attendance at
the ENT Clinic with otitis externa three years previously. At that time, treatment
with Tri-Adcortyl cream (Squibb; triamcinolone acetate, gramicidin, neomycin,
nystatin, ethylenediamine) was commenced, but later discontinued when a rash
occurred around the ear. She was referred to the dermatology clinic where patch
testing was performed. A strong positive reaction was found to ethylenediamine
(1 %) which is a standard allergen in the European Standard Battery. She had not
received aminophylline preparations in the past. The infusion of aminophylline
was therefore discontinued and the rash subsided over the next few days. It is
still possible that the allergen was ampicillin but a clear link to ethylenediamine
is evident.
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DISCUSSION
Ethylenediamine is a substance used as a binding agent in a number of products,
principally Tri-Adcortyl cream and aminophylline injection and enema. Reports
ofsensitization havebeen reported in hospital practiceand industry.2,3 Inaddition,
cross reaction has been observed with antihistamines4,5 and piperazine.6 The
allergic reaction can result in an exfoliative erythrodermic dermatitis which carries
a significant morbidity and mortality. Neither the presence of ethylenediamine,
nor the potential cross reaction are listed in the manufacturer's data sheet for
Tri-Adcortyl cream, orforanyofthecommonly used aminophylline preparations.
They are, however, mentioned in Martindale and the British Pharmacopoeia.
This case illustrates the importance of careful examination of medical notes for
such allergies, and clear warnings on the front cover of notes. It is also important
to warn general practitioners, and indeed the patients themselves, ofthe potential
risk. It is also worth remembering that in cases of drug allergy, the most obvious
suspect is not always the correct one.
We thank Dr J G Daly, Consultant Physician, Altnagelvin Hospital for permission to report this case.
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